Subscribe To

Price Alert Latest News Economic Calendar News

STXS / Stereotaxis to Present at Upcoming Investor Conferences

ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, chairman and CEO, will present at three investor conferences in the first quarter 2022. Read More

Demo Live Account See Partner Details

Content Topics

Stereotaxis

Present

Upcoming

Investor

Conferences

Stock

STXS

Posted: Feb 14 2022, 09:04

Author Name: GlobeNewsWire

STXS News

By GlobeNewsWire
October 17, 2023

Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023

ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovas

By Seeking Alpha
August 10, 2023

Stereotaxis, Inc. (STXS) Q2 2023 Earnings Call Transcript

Stereotaxis, Inc. (NYSE:STXS ) Q2 2023 Earnings Conference Call August 10, 2023 10:00 AM ET Company Participants David Fischel - Chairman & Chief Exec

By GlobeNewsWire
July 15, 2023

Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023

ST. LOUIS, July 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovas

By Zacks Investment Research
July 11, 2023

Down -32.11% in 4 Weeks, Here's Why You Should You Buy the Dip in Stereotaxis Inc. (STXS)

Stereotaxis Inc. (STXS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement

By GlobeNewsWire
May 25, 2023

Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference

ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovasc

By Seeking Alpha
March 3, 2023

Stereotaxis, Inc. (STXS) Q4 2022 Earnings Call Transcript

Stereotaxis, Inc. (NYSE:STXS ) Q4 2022 Earnings Conference Call March 3, 2023 10:00 AM ET Company Participants David Fischel - CEO & Chairman Kimberly

By GlobeNewsWire
February 21, 2023

Stereotaxis to Present at Cowen 43rd Annual Health Care Conference

ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovas

By Seeking Alpha
February 15, 2023

Catalysts Are Coming Soon For Stereotaxis

Stereotaxis, Inc. stock fell in 2022 because of new product delays and weak new orders. These delays and disappointing new orders were caused by macro

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.